Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea

Lung Cancer ◽  
2015 ◽  
Vol 87 (2) ◽  
pp. 148-154 ◽  
Author(s):  
Jin Ho Baek ◽  
Jong-Mu Sun ◽  
Young Joo Min ◽  
Eun Kyung Cho ◽  
Byoung Chul Cho ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Retrospective Analysis ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Exon 19 Deletion ◽  
Egfr Mutated ◽  
Exon 19

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

2019 ◽  
Vol 20 (2) ◽  
pp. 82-87 ◽  
Author(s):  
Sabrina Rossi ◽  
Luca Toschi ◽  
Giovanna Finocchiaro ◽  
Vincenzo Di Noia ◽  
Maria Bonomi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Exon 19 Deletion ◽  
Egfr Mutant ◽  
Exon 19

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

2017 ◽  
Vol 18 (1) ◽  
pp. 15-20 ◽  
Author(s):  
Giandomenico Roviello ◽  
Laura Zanotti ◽  
Maria Rosa Cappelletti ◽  
Angela Gobbi ◽  
Martina Dester ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitors ◽  
Egfr Mutated
Sign in / Sign up

Export Citation Format

Share Document